127 related articles for article (PubMed ID: 2876700)
1. A study of the need for anticholinergic medication in patients treated with long-term antipsychotics.
Caradoc-Davies G; Menkes DB; Clarkson HO; Mullen PE
Aust N Z J Psychiatry; 1986 Jun; 20(2):225-32. PubMed ID: 2876700
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs.
Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE
Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760
[TBL] [Abstract][Full Text] [Related]
4. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
Baker LA; Cheng LY; Amara IB
Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?
Desmarais JE; Beauclair L; Margolese HC
J Psychopharmacol; 2012 Sep; 26(9):1167-74. PubMed ID: 22651987
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
[TBL] [Abstract][Full Text] [Related]
7. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
8. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial.
Goff DC; Arana GW; Greenblatt DJ; Dupont R; Ornsteen M; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1991 Apr; 11(2):106-12. PubMed ID: 2056136
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of maintenance use of anticholinergic agents.
Double DB; Warren GC; Evans M; Rowlands RP
Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.
Bogunovic O; Viswanathan R
Psychosomatics; 2000; 41(3):277-8. PubMed ID: 10849461
[No Abstract] [Full Text] [Related]
11. Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes.
Keepers GA; Clappison VJ; Casey DE
Arch Gen Psychiatry; 1983 Oct; 40(10):1113-7. PubMed ID: 6138011
[TBL] [Abstract][Full Text] [Related]
12. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
[TBL] [Abstract][Full Text] [Related]
13. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Siris SG; Rifkin A; Reardon GT; November M
Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
[TBL] [Abstract][Full Text] [Related]
14. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic prophylaxis in young adults treated with neuroleptic drugs.
Lake CR; Casey DE; McEvoy JP; Siris SG; Boyer WF; Simpson G
Psychopharmacol Bull; 1986; 22(3):981-4. PubMed ID: 2879314
[No Abstract] [Full Text] [Related]
16. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
17. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
18. A pilot effort to determine benztropine equivalents of anticholinergic medications.
de Leon J; Canuso C; White AO; Simpson GM
Hosp Community Psychiatry; 1994 Jun; 45(6):606-7. PubMed ID: 8088744
[No Abstract] [Full Text] [Related]
19. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
Tauscher J; Küfferle B; Asenbaum S; Tauscher-Wisniewski S; Kasper S
Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
